These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1406373)

  • 1. Focus formation by the human immunodeficiency virus (HIV) in the immobilized MT-4 cell culture and its application to the evaluation of anti-HIV agents.
    Nakane M; Kawai A
    Microbiol Immunol; 1992; 36(7):707-19. PubMed ID: 1406373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel assay system for anti-human immunodeficiency virus type 1 (HIV-1) activity using a subclone of a monocytic cell line, U937.
    Miyano-Kurosaki N; Nakashima H; Ichiyama K; Inazawa K; Tabata H; Tanabe H; Ohnishi K; Mizusawa H; Ohshiro Y; Yamamoto N
    Microbiol Immunol; 1994; 38(10):813-8. PubMed ID: 7869961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
    Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
    AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HIV activity of dextran sulphate as determined under different experimental conditions.
    Nakashima H; Yoshida O; Baba M; De Clercq E; Yamamoto N
    Antiviral Res; 1989; 11(5-6):233-46. PubMed ID: 2478075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HIV compound assessment by two novel high capacity assays.
    Averett DR
    J Virol Methods; 1989 Mar; 23(3):263-76. PubMed ID: 2497128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.
    Eron JJ; Gorczyca P; Kaplan JC; D'Aquila RT
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3241-5. PubMed ID: 1565615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrazolium-based plaque assay for HIV-1 and HIV-2, and its use in the evaluation of antiviral compounds.
    Nakashima H; Pauwels R; Baba M; Schols D; Desmyter J; De Clercq E
    J Virol Methods; 1989 Dec; 26(3):319-29. PubMed ID: 2482843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human immunodeficiency virus type 1 replication by nonionic block polymer surfactants.
    Hirschman SZ; Zucker ML; Garfinkel E
    J Med Virol; 1994 Mar; 42(3):249-54. PubMed ID: 8006638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine.
    Levere RD; Gong YF; Kappas A; Bucher DJ; Wormser GP; Abraham NG
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1756-9. PubMed ID: 2000384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937).
    Uherová P; Schmidtmayerová H; Mayer V
    Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
    Bryant ML; Ratner L; Duronio RJ; Kishore NS; Devadas B; Adams SP; Gordon JI
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2055-9. PubMed ID: 2006142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
    Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
    Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
    Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
    Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized peripheral blood mononuclear cell culture assay for zidovudine susceptibility testing of clinical human immunodeficiency virus type 1 isolates: effect of reducing the numbers of replicates and concentrations.
    Marschner IC; Mayers DL; Erice A; Smeaton L; Johnson VA; Richman DD; Reichelderfer P; Japour AJ
    J Clin Microbiol; 1997 Mar; 35(3):756-8. PubMed ID: 9041428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to AZT of HIV-1 variants grown in Epstein-Barr virus-transformed B cell lines.
    Tremblay M; Wainberg MA
    J Infect Dis; 1989 Jul; 160(1):31-6. PubMed ID: 2543710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.